ONCO Stock Analysis: Buy, Sell, or Hold?
ONCO - Onconetix, Inc. Common Stock
$0.96
-0.12 (-11.53%)
▼
5d:
-2.48%
30d:
-16.18%
90d:
-49.05%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When ONCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ONCO shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ONCO shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ONCO is currently trading at $0.96, which is considered oversold relative to its 30-day fair value range of $0.97 to $1.14.
Technical Outlook: Technically, ONCO is in a downtrend. Immediate support is located at $0.92, while resistance sits at $1.31. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+841.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ONCO is in a downtrend. Immediate support is located at $0.92, while resistance sits at $1.31. Short-term momentum is weak, with the stock down 11.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+841.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.97 -
$1.14
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-11.5%)
- BULLISH: Trading 841.9% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$0.97 -
$1.14
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.31
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$9.00
(+841.9%)
Revenue Growth (YoY)
-78.9%
Share & Embed Analysis
Last updated: July 02, 2026 9:42 PM ET
Data refreshes hourly during market hours. Next update: 10:42 PM
Data refreshes hourly during market hours. Next update: 10:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ONCO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
3
Sells
0
Net
NEUTRAL
Recent Transactions
Financial Lp Hrt
SELL
49710 shares
2026-04-21
Financial Lp Hrt
SELL
94462 shares
2026-04-20
Financial Lp Hrt
BUY
34636 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 55 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 63 BUY |
